Guidance

Shingles vaccine (Shingrix庐): patient group direction (PGD) template

PGD template for Shingrix庐 vaccine for immunocompromised individuals.

From:
UK Health Security Agency
Published
31 August 2021
Last updated
15 November 2024 鈥� See all updates

Applies to England

Documents

Ref: UKHSA gateway number GOV-14999

MS Word Document, 185 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template is to support the administration of Shingrix庐 vaccine in accordance with the national shingles immunisation programme.

It is valid from 1 September 2023 to 30 September 2025, incorporating the changes to the national programme for immunocompetent adults aged 65 and over.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see ). Practitioners should follow local policy or procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and for the vaccine.

Updates to this page

Published 31 August 2021
Last updated 15 November 2024 show all updates

  1. Removed link to Zostavax PGD because this has expired.

  2. Added version 2.00 鈥� see page 2 for change history.

  3. First published.

Sign up for emails or print this page

Related content